Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) is a Financial Services · Shell Companies company listed on NASDAQ. Price $10.84 (+0.00%), Market cap $0.36B, P/E ratio 55.71, 52-week low–high $10.12 ~ $10.60.
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
Financial statements, price targets, institutional (13F) holdings and related news for Drugs Made In America Acquisition Corp. Ordinary Shares are updated in real time on BlackAll Trade.
Drugs Made In America Acquisition Corp. Ordinary Shares trades at $10.84 (+0.00%). Real-time quotes and charts are available on BlackAll Trade.
Drugs Made In America Acquisition Corp. Ordinary Shares has a market cap of about $0.36B. Its P/E ratio is 55.71.
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or oth